Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1CNS 1

Conditions

Lymphoma, Follicular 1Glioma 1Glioblastoma 1

Interventions

Temozolomide 4Specimen Handling 3Magnetic Resonance Spectroscopy 3Paclitaxel 2Gemcitabine 2Filgrastim 2Drug Therapy 2Cognitive Behavioral Therapy 2Blood Specimen Collection 2Azacitidine 2vocimagene amiretrorepvec 1trametinib 1sonidegib 1sargramostim 1ruxolitinib 1rucaparib 1ribociclib 1repotrectinib 1imetelstat 1fludarabine 1epacadostat 1dostarlimab 1depatuxizumab 1ceritinib 1cemiplimab 1cc-486 1carboxyamido-triazole 1acalabrutinib 1abiraterone 1Uncertainty 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × depatuxizumab × Lymphoid × Clear all
NCT02590263 2020-09-03

Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma

AbbVie

Phase 1/2 Completed
53 enrolled
CNSLymphoid

Glioblastoma, Glioma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡